SCHEMBL5279660

SCHEMBL5279660

O=S(=O)(NC[C@H](O)CN1CCCCC1)c1cccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5242085 1.00 SLC6A9 (1.00) SLC6A9
SCHEMBL5240894 0.99 SLC6A9 (1.00) SLC6A9
SCHEMBL8365107 0.99 SLC6A9 (1.00) SLC6A9
SCHEMBL5968436 0.88 SLC6A9 (0.81) SLC6A9
SCHEMBL8367114 0.86 SLC6A9 (0.77) SLC6A9
SCHEMBL14382140 0.85 SLC6A9 (1.00) SLC6A9
SCHEMBL14382102 0.85 SLC6A9 (1.00) SLC6A9
SCHEMBL14381241 0.84 SLC6A9 (0.74) SLC6A9
SCHEMBL5278409 0.82 SLC6A9 (1.00) SLC6A9
SCHEMBL5242125 0.82 SLC6A9 (1.00) SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455777-B1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2007-11-21 — — EP claimed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 — — WO disclosed
Send feedback